Benzothiazole Disulfide

What Drives Reversion Resistance in Truck Tire Cap Compounds?

Natural rubber truck tire cap compounds operating at >90°C continuous service in long-haul conditions are vulnerable to reversion — a thermal degradation of the polysulfidic crosslink network that progressively lowers modulus and accelerates wear. Incorporating benzothiazole disulfide (MBTS) as a secondary accelerator alongside a primary sulfenamide (typically CBS at 1.2–1.8 phr) shifts the vulcanization profile toward a slower, broader curing plateau. This adjustment raises the onset temperature of reversion by approximately 8–12°C compared to formulations relying solely on sulfenamide/thiuram combinations, as measured by moving-die rheometer torque decay at 180°C over 60 min per ISO 6502-2. The mechanism hinges on MBTS decomposing to generate 2‑mercaptobenzothiazole radicals that consume free sulfur more gradually, producing a mixed mono‑/disulfidic bond architecture that resists anaerobic thermal cleavage. Typical tread compound mixing follows a two‑pass internal mixer cycle: in a 270 L intermeshing Banbury with ram pressure 0.55 MPa, carbon black N234 (50–55 phr), oil, zinc oxide (3.5 phr), stearic acid (2.0 phr), antidegradants, and NR are masterbatched to a drop temperature of 145–155°C. After cooling on a batch-off unit to ≤40°C, the final pass incorporates MBTS at 0.4–0.8 phr with sulfur (1.2–1.8 phr) and CBS on a two‑roll mill set to 60–70°C nip temperature. Strict control ensures stockpile age <8 h before extrusion to minimize surface bloom. Extruded tread profiles are applied to buffed casings and cured in segmented mold presses at 151°C under 2.4 MPa internal steam pressure for 18–24 min. The resulting DIN 53505 abrasion indices routinely remain below 120 mm³ loss while maintaining a tan δ at 60°C of 0.12–0.14, indicating acceptable rolling resistance. Compliance with Regulation (EC) No. 2004/12 for retreaded commercial vehicle tires references test methods ISO 28580 (rolling resistance) and ISO 10191 (tread wear indicators). A key limitation: MBTS alone cannot prevent reversion in shoulder regions where local heat buildup exceeds 130°C; a semi‑EV shift using additional sulfur‑donor co‑curative is necessary.

Production‑line experience in large Chinese retread plants highlights a bottleneck during the final mix pass. When Banbury drop temperature inadvertently exceeds 105°C due to inadequate rotor cooling, the MBTS can initiate premature scorch measured as Mooney t5 at 121°C dropping below 10 min, rendering the stock unsuitable for continuous extrusion. To counter this, dispersion quality of MBTS must be verified by light‑optical microscopy on 100‑µm thin sections; agglomerates above 20 µm create local over‑cure domains visible as surface pits after 10,000‑km field trials. Therefore, MBTS is frequently pre‑weighed into low‑melt polyethylene bags that are introduced at 95°C ram position to guarantee homogeneous distribution without dust exposure meeting the occupational exposure limit of 0.5 mg/m³ (inhalable dust) under OSHA 29 CFR 1910.1200. No FDA‑specific compliance applies to tread applications, but REACH Annex XVII restrictions on PAH content in extender oils compel documentation of all compounding ingredients.

In the production of wrapped V‑belts and hydraulic hose jackets, MBTS serves as the primary accelerator where the manufacturing process demands a delayed onset of cure to allow sufficient flow time during the long forming stages. A representative NR/SBR blend (70/30) jacket formulation uses 1.0–1.5 phr MBTS combined with 0.1–0.2 phr TMTM as a kicker, with sulfur at 2.5 phr. The mixing is conducted in a 160 L tangential Banbury at a fill factor of 0.75, masterbatching carbon black N660 (65 phr), clay (20 phr), and plasticizers to a dump temperature of 130°C. The cure‑active phase is added on a cooling mill with a front roll temperature of 55°C and a friction ratio of 1:1.2 to avoid sticking. MBTS uptake is particularly sensitive to residual moisture — predrying at 50°C for 2 h is mandatory if RH exceeds 60% in the weigh‑up room, as moisture levels above 0.3% in the accelerator promote hydrolysis and reduce crosslink density by up to 8% (evidenced by delta torque reduction in an MDR 2000 at 160°C). V‑belt building involves wrapping the fabric‑reinforced rubber sheet onto a drum, followed by curing in an autoclave with a water‑air curing medium at 155°C and 0.8 MPa for 25–35 min. The MBTS‑driven cure cycle generates a crosslink density sufficient to pass the DIN 22102 abrasion and flex fatigue test with 300‑hour endurance without edge cracking. Hydraulic hose jackets manufactured to SAE J517 and EN 853 standards similarly benefit from the low bloom characteristic of MBTS, as any surface deposit would compromise mandrel lubrication and cause pinholes during lead‑sheath extrusion. A practical processing limit noted in continuous vulcanization lines is that when MBTS dosage exceeds 2.0 phr in a CR‑free NR jacket compound, the activation energy calculated by the Ozawa method drops below 85 kJ/mol, causing scorch in the extruder head at temperatures as low as 105°C. Thus, real‑time ultrasonic die‑pressure monitoring is employed to detect any viscosity rise signaling premature cure.

When Bonding NR to Mild Steel Inserts in Engine Mounts

Rubber‑to‑metal bonded automotive engine mounts require a graded modulus at the interface to prevent cavitation during cyclic loading. MBTS is incorporated at 0.6–0.9 phr in the NR body compound along with sulfenamide TBBS at 0.5 phr to produce a slower cure that coincides precisely with the adhesive film’s gelation window. The adhesive system, typically a two‑coat silane/epoxy‑modified primer plus Chemlok 205/220, reaches its optimal bonding state when the rubber compound attains 10–30% of its maximum cure state, corresponding to a MDR torque value of 2–4 dN·m at 150°C. MBTS delays the scorch point just enough so that when injection‑transfer mold pots press the compound through a 8‑gate cold‑runner system at 85°C, the Mooney viscosity at 100°C remains within 30–45 MU, ensuring complete cavity fill before the adhesive begins to co‑cure. Mold clamping force on a 400‑ton vertical injection press is set to 21 MPa specific pressure. Cure time is 6–8 min at 160°C, followed by a post‑cure in a hot air oven at 110°C for 4 h to drive the reaction of residual isocyanates in the adhesive layer. Bond durability is assessed per ASTM D429 method B (90° peel) with a minimum peel adhesion of 8 kN/m required by automotive OEM specifications. The presence of MBTS in the rubber formulation must be carefully controlled because free 2‑mercaptobenzothiazole residues — generated during vulcanization — can migrate to the rubber‑steel interface and chelate iron ions, potentially promoting under‑film corrosion under cyclic salt spray (ISO 9227, 240 h). To mitigate this, the compound is always formulated with an additional 0.5 phr of a bismaleimide antireversion agent and 5 phr zinc oxide to sequester mercaptan species. Production batches that exhibit an acetone‑extractable mercaptobenzothiazole content above 0.08 wt%, determined by UV‑Vis at 320 nm, are rejected for engine mount service. Compliance for under‑hood elastomeric components references GMW 3056, with low‑emission requirements imposing a formaldehyde emission limit of ≤3 mg/kg per VDA 275, which is unaffected by MBTS substitution.

A recurrent processing failure observed in Chinese Tier‑1 plants: when the metal inserts are not preheated to at least 80°C before adhesive dipping, the colder steel surface delays local gelation, and the MBTS‑retarded rubber cure widens the T90 window, which reduces interfacial bond strength by up to 25%. Thermal imaging of pre‑cure fixtures has become a standard in‑process control to guarantee a ±5°C tolerance on insert temperature.

Cellular EVA Crosslinking: A Peroxide‑Activated Coagent System?

In the production of microcellular ethylene‑vinyl acetate (EVA) foams for athletic midsoles, MBTS is not used as a conventional accelerator but rather as a sulfur‑donor coagent in peroxide‑cured systems to modify the crosslink network topology and improve tear strength at low density (0.15–0.25 g/cm³). The standard formulation combines EVA (VA content 18–28%), azodicarbonamide blowing agent (2.5–4.0 phr), dicumyl peroxide (0.6–0.9 phr), and MBTS at 0.2–0.5 phr. MBTS interacts with the peroxide decomposition intermediates, grafting benzothiazole‑terminated side chains that create covalent entanglement points between EVA chains during the press‑foaming stage. Without MBTS, the foam exhibits a split‑tear strength (ISO 34-1, method A) of 1.2–1.5 N/mm; with the optimized MBTS addition, tear values increase to 2.0–2.4 N/mm at equal density. The foaming process is conducted in a two‑stage flatbed press: first stage 160°C at 15 MPa for 10 min to crosslink and partially decompose the blowing agent, followed by rapid decompression to atmospheric pressure and expansion in a secondary oven at 70°C for 45 min. MBTS requires pre‑mixing into a masterbatch (1:4 ratio with EVA wax) by melt‑blending in a 40 L/D co‑rotating twin‑screw extruder at 90°C to guarantee dispersion below 5 µm particle size, because undispersed MBTS agglomerates form visible brown spots on finished white foam and cause localized density variations exceeding ±0.03 g/cm³. The final molder must comply with REACH Annex XVII entry 50 for PAH limits (<1 mg/kg) when the foam is in prolonged skin contact; MBTS, being crystalline and insoluble in sweat simulant at pH 5.5, does not present migration risks above 10 µg/dm² per EN 16711.

Prevulcanized natural rubber latex formulations destined for surgical glove dipping lines often substitute part of the conventional thiocarbamate accelerators with MBTS to reduce the extractable protein level and minimize the risk of Type I hypersensitivity while maintaining adequate film tensile properties. In a batch process latex (DRC 60%), MBTS is added as a 50% aqueous dispersion at 0.5–0.8 phr with zinc dibutyldithiocarbamate (ZDBC) at 0.3 phr and sulfur at 1.0 phr. The compounded latex is matured under slow agitation for 16–24 h at 25–30°C to allow the ammonia‑preserved latex to reach an optimum chloroform number of 3–4, indicating partial pre‑vulcanization. Dipping is carried out on a continuous chain machine with ceramic formers pre‑heated to 55°C, dipped into coagulant (calcium nitrate 15% solution), then into the compounded latex for a dwell time of 15–20 s. Cure is completed in a hot air oven at 100–120°C for 20–30 min. MBTS, unlike thiuram‑based accelerators, does not generate secondary amines during vulcanization, thereby eliminating the source of N‑nitrosamines tested per EN 12868. Films cured with MBTS display a tensile strength of 18–22 MPa before aging and an elongation at break of 750–850% (ASTM D412 die C), which is within the acceptance envelope of ASTM D3578 for examination gloves. A critical processing parameter is the particle size of the MBTS dispersion, which must pass through a 5 µm screen residue test (<0.01% retention) to avoid pinhole formation in films thinner than 0.10 mm. Since MBTS is practically insoluble in water (<0.001 g/L at 25°C), sedimentation in the latex bath can occur if agitation stops for more than 30 min, requiring peristaltic recirculation loops to maintain homogeneity. The acrylic latex‑coated glove with MBTS shows a Type IV allergy patch test negative result owing to the absence of thiuram sulfide residues, compliant with the Medical Device Directive 93/42/EEC.

Elastomeric Closure Compliance Verification Under EP 3.2.9

Rubber closures for injectable pharmaceutical vials demand an exceptionally low extractables profile, and MBTS‑based cure packages are selected because they generate fewer zinc alkyl dithiocarbamate residues compared to conventional dithiocarbamate accelerators, while still achieving a crosslink density that passes the fragmentation test of EP 3.2.9. A typical halobutyl rubber stopper formulation for aqueous parenterals uses bromobutyl (BIIR) with calcined kaolin filler (60 phr), magnesium oxide (0.15 phr), and a cure system consisting of 1.2 phr MBTS, 0.3 phr ZDBC, and 0.8 phr sulfur. The mixing is executed in a 5 L laboratory internal mixer with full cooling jacket and a ram pressure of 0.5 MPa, with the MBTS added after filler incorporation at a dump temperature of 105°C. The sheeted compound is then compression‑molded in multi‑cavity tools at 175°C for 8 min and post‑cured for 2 h at 120°C to complete the vulcanization and evaporate volatile oligomers. Extraction tests of finished closures according to EP 3.2.9 involve autoclaving the stoppers in water at 121°C for 30 min; the resulting extract must exhibit an absorbance at 220–360 nm below 0.2, a residue on evaporation less than 4 mg/100 mL, and a heavy metals content <2 ppm. MBTS‑cured closures regularly meet these criteria because the benzothiazole breakdown products are largely bound into the polymer network, and what little free MBT migrates can be removed by a final water rinse at 95°C for 10 min. US FDA 21 CFR 177.2600 permits the use of MBTS as a vulcanizing agent in rubber articles intended for repeated use in contact with food, which is cross‑referenced for drug delivery components under FDA guidance “Container Closure Systems for Packaging Human Drugs and Biologics.” An industry‑specific restriction: closure compounds for lyophilized products that require low moisture vapor transmission (<0.03 g/m²/day) should limit MBTS to below 1.0 phr because zinc mercaptide by‑products increase hydrophilicity by approximately 15% as verified by contact angle measurements per ASTM D5946.

When service temperatures exceed 120°C and dynamic exposure dictates a mono‑sulfidic crosslink network, MBTS performs as a sulfur donor rather than as an accelerator, releasing active sulfur at a controlled rate during the cure plateau. Industrial O‑rings and gaskets molded from EPDM (ethylene content 55%, ENB 5.5%) rely on a semi‑EV cure system composed of elemental sulfur (0.3 phr), MBTS (2.0–2.8 phr), and tetramethylthiuram disulfide (TMTD, 0.5 phr) to generate a network with predominantly mono‑ and disulfidic bridges. The effective sulfur content of commercial benzothiazole disulfide is approximately 27%, and this value is used to compute the total sulfur input for designing the crosslink density target of νₑ ≈ 1.8×10⁻⁴ mol/cm³ (swelling equilibrium in n‑heptane per ASTM D471). Mixing is performed in a 55 L internal mixer with intermeshing rotors, combining EPDM, carbon black N550 (80 phr), paraffinic oil (50 phr), and processing aids in an upside‑down procedure. MBTS is introduced at 90°C after the second oil increment to ensure dispersal without premature sulfur release. Compression molding at 180°C for 4 min yields a state of cure confirmed by rheometer t90 <5 min. The finished parts exhibit compression set values below 20% after 22 h at 150°C (ISO 815-1) and retain 85% of original tensile strength after aging 168 h at 150°C. A critical operational boundary: when MBTS is the sole sulfur source above 3.5 phr, zinc mercaptide bloom appears on the molding surface within 48 h of storage at <25°C, compromising seal integrity. Therefore, the compound is always test‑molded and inspected under 10x magnification before release to mass production. The low‑sulfur donor approach aligns with EN 681‑1 for elastomeric seals in water supply applications, as it minimizes leachable sulfides that could cause chloramine degradation in potable water environments.